Reports state that long non-coding RNA (lncRNA) fricr is comparable to the Foxp3 genome and has the ability to act cis on Foxp3’s transcription process, decreasing its stability (12); additionally, miR-125b has been shown in thyroid cancer research to target Foxp3 and suppress its mRNA and protein production while increasing cancer cells’ susceptibility to cisplatin treatments (14). The gene discussed is FOXP3; the disease is thyroid cancer.